Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › FL › DAVIE › AMERICAN HEALTH S, LLC

AMERICAN HEALTH S, LLC

NPI: 1295823540 · DAVIE, FL 33331 · Clinical Medical Laboratory · NPI assigned 10/11/2006

$9.17M
Total Medicaid Paid
6,719,476
Total Claims
3,277,792
Beneficiaries
157
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMARTIN, CHRIS (PRESIDENT)
NPI Enumeration Date10/11/2006

Related Entities

Other providers sharing the same authorized official: MARTIN, CHRIS

ProviderCityStateTotal Paid
AMERICAN HEALTH NE, LLC MANSFIELD MA $96K
AMERICAN HEALTH S, LLC COLUMBIA MD $10K
COLUMBIA NEPHROLOGY & INTERNAL MEDICINE, PC COLUMBIA MO $2K
AMERICAN HEALTH W LLC RENTON WA $180.61

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 701,748 $791K
2019 911,792 $681K
2020 1,356,085 $2.46M
2021 1,255,109 $3.16M
2022 1,127,238 $1.08M
2023 887,735 $763K
2024 479,769 $242K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 279,524 77,645 $4.28M
80053 Comprehensive metabolic panel 581,410 303,771 $682K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 729,070 337,821 $574K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 121,840 72,324 $412K
80048 Basic metabolic panel (calcium, ionized) 430,065 188,394 $398K
84443 Thyroid stimulating hormone (TSH) 224,102 125,487 $307K
80061 Lipid panel 199,370 123,853 $239K
83036 Hemoglobin; glycosylated (A1C) 225,391 138,596 $214K
87086 Culture, bacterial; quantitative colony count, urine 185,489 110,253 $150K
36415 Collection of venous blood by venipuncture 359,665 143,219 $125K
85027 207,764 110,866 $121K
82607 86,664 50,217 $106K
87077 119,966 74,846 $100K
87186 120,198 74,859 $93K
80164 63,628 36,406 $92K
83880 35,320 20,318 $85K
85610 177,631 30,807 $77K
80177 32,215 18,558 $72K
83735 87,604 47,331 $63K
80202 26,998 5,600 $59K
82140 40,638 20,632 $58K
83970 10,898 5,902 $55K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 143,511 78,659 $45K
82746 50,912 28,076 $44K
87040 18,846 2,853 $43K
82728 31,383 18,799 $35K
81001 72,470 45,759 $33K
80185 14,738 6,894 $31K
84134 17,695 9,855 $28K
86140 43,932 13,069 $22K
87493 7,622 4,518 $22K
84153 9,457 5,921 $22K
87070 19,243 10,986 $22K
80050 General health panel 3,376 2,233 $20K
80074 2,268 1,091 $19K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,945 994 $19K
80076 16,175 9,821 $18K
85651 35,977 14,294 $17K
83540 38,495 23,790 $17K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 88,581 24,258 $17K
81000 88,759 53,497 $16K
84439 31,129 17,867 $16K
87536 656 369 $14K
83550 22,592 14,029 $14K
86141 8,734 3,416 $12K
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled 469,636 232,688 $12K
84480 12,021 6,669 $12K
80156 6,206 3,478 $11K
84100 19,401 9,935 $11K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2,096 827 $9K
82248 17,309 10,173 $9K
84132 13,275 6,368 $9K
81003 43,732 24,884 $9K
84436 20,189 12,134 $9K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 726 490 $8K
84481 3,914 2,477 $7K
86803 2,772 1,148 $7K
86360 968 553 $7K
80069 8,373 4,729 $6K
87045 6,249 3,757 $6K
82565 9,206 4,446 $6K
80162 7,388 4,602 $6K
87276 3,434 1,874 $5K
80184 3,843 2,447 $5K
84466 4,768 2,810 $5K
84550 15,829 10,102 $5K
82550 7,144 3,642 $5K
87275 3,432 1,871 $5K
85018 22,507 8,313 $4K
80178 5,011 2,715 $4K
85014 21,278 7,769 $4K
85730 6,147 3,406 $4K
82040 6,912 4,462 $4K
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) 764,930 334,031 $4K
86480 118 87 $3K
83690 3,969 2,473 $3K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 246 163 $3K
84479 7,406 4,643 $3K
82043 6,114 3,923 $3K
85044 8,539 5,161 $3K
82570 5,991 3,842 $3K
86038 1,689 879 $3K
85379 2,478 1,132 $3K
86769 1,737 946 $3K
82150 3,051 1,868 $2K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 3,596 2,199 $2K
83615 2,393 1,170 $2K
82272 7,291 3,762 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 461 266 $2K
84520 4,384 2,233 $2K
80175 2,253 1,545 $2K
86706 634 270 $2K
86430 1,521 825 $1K
84484 1,677 847 $1K
G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source 460 258 $1K
84403 734 424 $1K
82397 2,208 897 $1K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 87 57 $1K
84155 4,354 2,818 $1K
82310 1,672 986 $1K
87340 550 226 $1K
84460 2,976 1,860 $992.32
85049 2,135 986 $926.02
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 66 49 $710.75
84295 1,322 718 $704.11
82274 1,204 653 $697.75
82977 442 274 $685.52
82947 1,589 1,022 $656.88
84450 1,639 1,054 $610.46
80299 606 379 $581.62
85378 1,219 554 $508.31
86320 255 160 $456.07
82378 244 158 $395.90
80170 397 120 $379.76
82247 838 512 $346.46
84075 925 570 $331.76
84146 207 94 $325.76
86592 380 180 $304.76
85008 416 241 $292.60
82374 439 339 $209.14
82435 439 340 $197.31
83605 167 74 $180.82
82552 253 124 $158.44
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 73 50 $126.45
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 49 36 $121.65
87177 303 169 $114.68
84478 146 99 $112.39
80188 300 195 $100.31
80183 20 13 $80.56
87081 189 115 $64.16
83721 157 122 $50.36
87280 107 59 $49.75
80235 33 25 $41.12
87279 78 37 $37.33
87260 79 38 $32.96
86039 122 82 $32.29
82270 141 89 $24.80
82784 21 13 $21.87
84300 75 29 $21.60
82465 140 99 $21.58
82172 114 70 $17.90
80051 70 59 $13.76
84425 69 46 $12.62
80201 23 13 $11.34
83718 94 71 $10.12
84165 23 12 $7.32
83001 26 13 $3.72
83930 18 13 $0.79
87522 Neg quan hep c or qual rna 21 13 $0.00
88304 18 15 $0.00
83695 69 40 $0.00
87631 50 29 $0.00
86787 111 45 $0.00
82652 56 38 $0.00
85004 101 44 $0.00
84630 34 20 $0.00
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 133 67 $0.00